Malignant Esophageal Neoplasm — Trials

Malignant Esophageal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,926 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 518
Recruiting: 302
Ph III recruiting: 41
Growth YoY: +2.4%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 28.5%
Trials / 1,000 deaths: 32.3 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (169)

clinicaltrialsPublishedShowing 151–200 of 660 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03917043	APG-2449 in Patients With Advanced Solid Tumors	recruiting	Phase 1	165	Ascentage Pharma Group Inc.INDUSTRY	1	Jul 23, 2026	clinicaltrials
NCT05028725	Novel Strategy for Early Detection of Esophageal Squamous Cell Carcinoma	recruiting	N/A	289	University of California, San FranciscoOTHER	1	Jul 23, 2026	clinicaltrials